5 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Terminated 5 |
Follow Peripheral Neuropathy: new trials by email Literature Review of Peripheral Neuropathy trials Research Report on Peripheral Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy Nicotine Transdermal Patch - Neuropathy, Peripheral Neuropathy | Phase 2 | Terminated | Virginia Commonwealth University | 4 | 2020-07-31 | 2023-11-08 |
| Candesartan in Peripheral Neuropathy Candesartan, Usual care - Peripheral Neuropathy | Phase 2 | Terminated | University Hospital, Limoges | 9 | 2019-05-01 | 2021-11-15 |
| Glutamine in Preventing Peripheral Neuropathy in Patients With Multiple Myeloma Receiving Bortezomib glutamine, quality-of-life assessment, placebo - Chemotherapeutic Agent Toxicity, Multiple Myeloma | Phase 2 | Terminated | Beth Faiman | 9 | 2013-02-01 | 2019-10-22 |
| The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment Placebo, Tetrodotoxin - Pain, Peripheral Neuropathy | Phase 2 | Terminated | Wex Pharmaceuticals Inc. | 125 | 2012-07-01 | 2018-10-30 |
| Combination Pain Therapy in HIV Neuropathy Duloxetine, Duloxetine placebo, Methadone - HIV Infections, Peripheral Neuropathy | Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 15 | 2009-05-01 | 2021-11-04 |
Peripheral Nervous System Diseases (5) · Neuralgia (2) · Pain (2) · HIV Infections (1) · Multiple Myeloma (1)
Nervous System Diseases (5) · Neuromuscular Diseases (5) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Immune System Diseases (2) · Blood Protein Disorders (1) · Blood-Borne Infections (1) · Cardiovascular Diseases (1) · Communicable Diseases (1) · Genital Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1)
Duloxetine Hydrochloride (1) · Glutamine (1) · Injections (1) · Methadone (1) · Tetrodotoxin (1) · Tobacco Use Cessation Devices (1) · candesartan (1)
Beth Faiman (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · University Hospital, Limoges (1) · Virginia Commonwealth University (1) · Wex Pharmaceuticals Inc. (1)
United States (4) · France (1)
Beth Faiman (1) · David B. Clifford, MD (1) · Renato Martins, MD (1) · Samuel Goldlust, MD (1) · Taylor B. Harrison, MD (1)